<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941107-2-00232</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=74 g=1 f=1 --> References <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1. Garner JS. The CDC Hospital Infection Control Practices Advisory Committee.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Am J Infect Control <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1993;21:160&hyph;162.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. National Communicable Disease Center.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Isolation Techniques for Use in Hospitals,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1st ed. Washington: U.S. Government Printing Office; 1970. PHS Publ. No. 2054.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Center for Disease Control.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Isolation Techniques for Use in Hospitals,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 2nd ed. Washington: U.S. Government Printing Office; 1975. HHS Publ. No. (CDC) 80&hyph;8314.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4. Garner JS, Simmons BP. CDC guideline for isolation precautions in hospitals.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Am J Infect Control <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1984;12:103&hyph;163,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Infect Control <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1983;4:245&hyph;325, and U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control, Atlanta; 1983. HHS Publ. No. (CDC) 83&hyph;8314.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5. Lynch T.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Communicable Disease Nursing.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> St. Louis: Mosby, 1949.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 6. Gage ND, Landon JF, Sider MT.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Communicable Disease.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Philadelphia: FA Davis, 1959.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 7. Haley RW, Shachtman RH. The emergence of infection surveillance and control programs in U.S. hospitals: an assessment, 1976.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Am J Epidemiol  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1980;111:574&hyph;591.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 8. Schaffner W. Infection control: Old myths and new realities.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Infect Control  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1980;1:330&hyph;334.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 9. Garner JS. Comments on CDC guideline for isolation precautions in hospitals, 1984.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Am J Infect Control <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1984;12:163.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 10. Haley RW, Garner JS, Simmons BP. A new approach to the isolation of patients with infectious diseases: alternative systems.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> J Hosp Infect  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1985;6:128&hyph;139.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 11. Nauseef WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> N Engl J Med  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1981;304:448&hyph;453.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 12. Pizzo PA. The value of protective isolation in preventing nosocomial infections in high risk patients.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Am J Med  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1981;70:631&hyph;637.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 13. Jacobson JT, Johnson DS, Ross CA, Conti MT, Evans RS, Burke JP. Adapting disease-specific isolation guidelines to a hospital information system.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Infect Control  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1986;7:411&hyph;418.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 14. Goldmann DA. The role of barrier precautions in infection control.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> J Hosp Infect  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1991;18:515&hyph;523.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 15. Goldmann D, Platt R, Hopkins C. Control of hospital-acquired infections. In: Gorbach SL, Bartlett JG, Blacklow NR, eds.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Infectious Diseases.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Philadelphia:WB Saunders, 1992:chap 45:378&hyph;390.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 16. Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> MMWR  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1988;37(3S):1&hyph;16.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 17. Centers for Disease Control. Risks associated with human parvovirus B19 infection.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> MMWR <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1989;38:81&hyph;88,93&hyph;97.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 18. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> MMWR <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1990;39(RR&hyph;17):1&hyph;29.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 19. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital_Florida.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> MMWR <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1990;39:718&hyph;722.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 20. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons_Florida and New York, 1988&hyph;1991.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> MMWR <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1991;40:585&hyph;591.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 21. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> MMWR <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1993;42(RR&hyph;7):1&hyph;8.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 22. Centers for Disease Control and Prevention. Draft guidelines for preventing the transmission of tuberculosis in health-care facilities, second edition.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  1993;58(195):52810&hyph;52850.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            